Think they'll have to go through an extra approval for Europe for sure. Can't imagine they'll just wave it through just because of an FDA approval. Not sure though.
Market wise I do not know which is "more" relevant in terms of people in need. Can surly be found out without much research. Maybe something for tomorrow while we continue to play the waiting game here
PAR -v- CUV, page-14
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.8¢ | 23.0¢ | $155.1K | 661.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 365364 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 11500 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |